3e67
From Proteopedia
(Difference between revisions)
Line 3: | Line 3: | ||
<StructureSection load='3e67' size='340' side='right'caption='[[3e67]], [[Resolution|resolution]] 2.60Å' scene=''> | <StructureSection load='3e67' size='340' side='right'caption='[[3e67]], [[Resolution|resolution]] 2.60Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[3e67]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/ | + | <table><tr><td colspan='2'>[[3e67]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3E67 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3E67 FirstGlance]. <br> |
- | </td></tr><tr id=' | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.6Å</td></tr> |
- | <tr id=' | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BVF:4-METHYLPYRIDIN-2-AMINE'>BVF</scene>, <scene name='pdbligand=H4B:5,6,7,8-TETRAHYDROBIOPTERIN'>H4B</scene>, <scene name='pdbligand=HEM:PROTOPORPHYRIN+IX+CONTAINING+FE'>HEM</scene></td></tr> |
- | + | ||
- | + | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3e67 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3e67 OCA], [https://pdbe.org/3e67 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3e67 RCSB], [https://www.ebi.ac.uk/pdbsum/3e67 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3e67 ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3e67 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3e67 OCA], [https://pdbe.org/3e67 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3e67 RCSB], [https://www.ebi.ac.uk/pdbsum/3e67 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3e67 ProSAT]</span></td></tr> | ||
</table> | </table> | ||
== Function == | == Function == | ||
- | + | [https://www.uniprot.org/uniprot/NOS2_MOUSE NOS2_MOUSE] Produces nitric oxide (NO) which is a messenger molecule with diverse functions throughout the body. In macrophages, NO mediates tumoricidal and bactericidal actions. Also has nitrosylase activity and mediates cysteine S-nitrosylation of cytoplasmic target proteins such COX2.<ref>PMID:16373578</ref> | |
== Evolutionary Conservation == | == Evolutionary Conservation == | ||
[[Image:Consurf_key_small.gif|200px|right]] | [[Image:Consurf_key_small.gif|200px|right]] | ||
Line 22: | Line 20: | ||
</jmol>, as determined by [http://consurfdb.tau.ac.il/ ConSurfDB]. You may read the [[Conservation%2C_Evolutionary|explanation]] of the method and the full data available from [http://bental.tau.ac.il/new_ConSurfDB/main_output.php?pdb_ID=3e67 ConSurf]. | </jmol>, as determined by [http://consurfdb.tau.ac.il/ ConSurfDB]. You may read the [[Conservation%2C_Evolutionary|explanation]] of the method and the full data available from [http://bental.tau.ac.il/new_ConSurfDB/main_output.php?pdb_ID=3e67 ConSurf]. | ||
<div style="clear:both"></div> | <div style="clear:both"></div> | ||
- | <div style="background-color:#fffaf0;"> | ||
- | == Publication Abstract from PubMed == | ||
- | Nitric oxide synthase (NOS) enzymes synthesize nitric oxide, a signal for vasodilatation and neurotransmission at low concentrations and a defensive cytotoxin at higher concentrations. The high active site conservation among all three NOS isozymes hinders the design of selective NOS inhibitors to treat inflammation, arthritis, stroke, septic shock and cancer. Our crystal structures and mutagenesis results identified an isozyme-specific induced-fit binding mode linking a cascade of conformational changes to a new specificity pocket. Plasticity of an isozyme-specific triad of distant second- and third-shell residues modulates conformational changes of invariant first-shell residues to determine inhibitor selectivity. To design potent and selective NOS inhibitors, we developed the anchored plasticity approach: anchor an inhibitor core in a conserved binding pocket, then extend rigid bulky substituents toward remote specificity pockets, which become accessible upon conformational changes of flexible residues. This approach exemplifies general principles for the design of selective enzyme inhibitors that overcome strong active site conservation. | ||
- | |||
- | Anchored plasticity opens doors for selective inhibitor design in nitric oxide synthase.,Garcin ED, Arvai AS, Rosenfeld RJ, Kroeger MD, Crane BR, Andersson G, Andrews G, Hamley PJ, Mallinder PR, Nicholls DJ, St-Gallay SA, Tinker AC, Gensmantel NP, Mete A, Cheshire DR, Connolly S, Stuehr DJ, Aberg A, Wallace AV, Tainer JA, Getzoff ED Nat Chem Biol. 2008 Nov;4(11):700-7. Epub 2008 Oct 12. PMID:18849972<ref>PMID:18849972</ref> | ||
- | |||
- | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
- | </div> | ||
- | <div class="pdbe-citations 3e67" style="background-color:#fffaf0;"></div> | ||
==See Also== | ==See Also== | ||
Line 39: | Line 28: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
- | [[Category: | + | [[Category: Mus musculus]] |
- | [[Category: Aberg | + | [[Category: Aberg A]] |
- | [[Category: Andersson | + | [[Category: Andersson G]] |
- | [[Category: Andrews | + | [[Category: Andrews G]] |
- | [[Category: Arvai | + | [[Category: Arvai AS]] |
- | [[Category: Cheshire | + | [[Category: Cheshire DR]] |
- | [[Category: Connolly | + | [[Category: Connolly S]] |
- | [[Category: Crane | + | [[Category: Crane BR]] |
- | [[Category: Garcin | + | [[Category: Garcin ED]] |
- | [[Category: Gensmantel | + | [[Category: Gensmantel NP]] |
- | [[Category: Getzoff | + | [[Category: Getzoff ED]] |
- | [[Category: Hamley | + | [[Category: Hamley PJ]] |
- | [[Category: Kroeger | + | [[Category: Kroeger MD]] |
- | [[Category: Mallinder | + | [[Category: Mallinder PR]] |
- | [[Category: Mete | + | [[Category: Mete A]] |
- | [[Category: Nicholls | + | [[Category: Nicholls DJ]] |
- | [[Category: Rosenfeld | + | [[Category: Rosenfeld RJ]] |
- | [[Category: St-Gallay | + | [[Category: St-Gallay SA]] |
- | [[Category: Stueh | + | [[Category: Stueh DJ]] |
- | [[Category: Tainer | + | [[Category: Tainer JA]] |
- | [[Category: Tinker | + | [[Category: Tinker AC]] |
- | [[Category: Wallace | + | [[Category: Wallace AV]] |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + |
Current revision
Murine inos dimer with inhibitor 4-MAP bound
|
Categories: Large Structures | Mus musculus | Aberg A | Andersson G | Andrews G | Arvai AS | Cheshire DR | Connolly S | Crane BR | Garcin ED | Gensmantel NP | Getzoff ED | Hamley PJ | Kroeger MD | Mallinder PR | Mete A | Nicholls DJ | Rosenfeld RJ | St-Gallay SA | Stueh DJ | Tainer JA | Tinker AC | Wallace AV